Show source-provided references
1. Cancer statistics, 2025
2. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
12. NF-kappaB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment
10.1126/sciadv.adq5226 ↗14. 25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages
10.1016/j.immuni.2024.03.021 ↗15. Thermosensitive Resiquimod-Loaded Lipid Nanoparticles Promote the Polarization of Tumor-Associated Macrophages to Enhance Bladder Cancer Immunotherapy
10.1021/acsnano.4c17444 ↗16. Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine Applications
10.1021/acsnano.3c11374 ↗18. Synthesis of Iron Nanometallic Glasses and Their Application in Cancer Therapy by a Localized Fenton Reaction
10.1002/anie.201510031 ↗20. Coordination Self-Assembly of a Carrier-Free Hyaluronic Acid-Modified Nanoplatform for Augmented Photothermal/Chemodynamic Therapy and Robust Antimetastatic Immunity
10.1021/acsami.5c24185 ↗21. Mitigating Doxorubicin-Induced Cardiotoxicity and Enhancing Anti-Tumor Efficacy with a Metformin-Integrated Self-Assembled Nanomedicine
10.1002/advs.202415227 ↗23. Concurrent Amplification of Ferroptosis and Immune System Activation Via Nanomedicine-Mediated Radiosensitization for Triple-Negative Breast Cancer Therapy
10.1002/advs.202407833 ↗26. Tumor acidification and GSH depletion by bimetallic composite nanoparticles for enhanced chemodynamic therapy of TNBC
10.1186/s12951-024-02308-8 ↗28. cGAS-STING, an important signaling pathway in diseases and their therapy
10.1002/mco2.511 ↗30. Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity
10.1038/s41467-023-39607-x ↗34. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy
10.1021/acsami.0c01539 ↗36. Metal-organic framework-based hydrogel with structurally dynamic properties as a stimuli-responsive localized drug delivery system for cancer therapy
10.1016/j.actbio.2022.04.003 ↗